Top 5 Most-Viewed Content in Leukemia and Lymphoma for 2022
December 20th 2022The top 5 most-read content in leukemia and lymphoma for 2022 addressed chimeric antigen receptor T-cell therapy, updates in recommended treatment, and President Joe Biden’s announcement on the return of the Cancer Moonshot.
Read More
Analysis of Beti-Cel for Severe β-Thalassemia Shows Extensive, Long-term Patient Improvement
December 20th 2022A pair of abstracts presented at this year’s 64th American Society of Hematology Annual Meeting and Exposition bear out the significant transfusion-free rate at 3 years following beti-cell administration and marked improvements in patient-reported outcomes, including the ability to work and be physically active.
Read More
Top 5 Most-Read Articles About Automated Insulin Delivery in 2022
December 20th 2022Content published on AJMC.com focusing on automated insulin delivery devices over the past year highlighted utilization of these devices by age, compared different types of systems, looked at barriers to uptake, and examined equity issues standing in the way of access.
Read More
Among young adults, 2-year cancer survival increased more in states with expanded Medicaid coverage; some pharmacies implemented purchase limits to help combat children’s medicine supply shortages; an FDA advisory panel will meet next month to discuss the state of the COVID-19 pandemic.
Read More
Spirometry Requirements May Exclude Patients With COPD From Palliative Care Research
December 19th 2022New study findings call into question the necessity of spirometry as a criterion for participation in palliative care research among patients with chronic obstructive pulmonary disease (COPD).
Read More
Postoperative TACE Prolongs RFS in Patients With Combined Hepatocellular-Cholangiocarcinoma
December 19th 2022Overall survival for patients with combined hepatocellular-cholangiocarcinoma is poor, but those who received adjuvant transarterial chemoembolization (TACE) after surgery had a prolonged recurrence-free survival (RFS).
Read More
Dr Martin Levine Explains the Growing Need for Caregiver Support in Alzheimer Disease
December 19th 2022Martin Levine, MD, MBA, chief medical officer at the PolyClinic at Optum Washington, describes why caregivers need more resources to adequately manage patients with Alzheimer disease and what clinics can do to ensure access to those resources.
Watch
What We’re Reading: Lilly Diabetes Drug Shortage; Medicare Data Breach; New Model for Antibiotics
December 19th 2022Eli Lilly is experiencing a shortage of the diabetes drug tirzepatide (Mounjaro); a data breach has caused over 200,000 Medicare enrollees to receive new identification cards; a restructuring of the current model for developing and selling antibiotics could be a solution to shortages and drug-resistant germs.
Read More
ASXL1 Mutations Associated With Worse Prognosis in MDS and AML
December 18th 2022A recent meta-analysis found ASXL1 mutations to be independent risk factors for worse overall survival and transformation to acute myeloid leukemia in patients with myelodysplastic syndromes (MDS), as well as worse overall survival in acute myeloid leukemia (AML).
Read More
T1D Community Helped Create T1D Index, Says JDRF's Tom Robinson
December 17th 2022Tom Robinson, vice president of global access at JDRF, talks about how the community and people living with type 1 diabetes (T1D) have contributed to the T1D Index, from development to publication and going forward.
Watch
ICYMI: Highlights From the 2022 American Academy of Dermatology Meeting
December 17th 2022This American Academy of Dermatology (AAD) Annual Meeting covered a breakthrough therapy for the management of vitiligo, clinical and epidemiological differences of certain dermatologic diseases, and the role of dietary triggers on patient outcomes.
Read More
Dr Patrick Reville Covers Study Results on Venetoclax Combined With CLIA
December 16th 2022Patrick Reville, MD, MPH, instructor, Department of Leukemia, MD Anderson Cancer Center, discusses findings on an updated treatment regimen for newly-diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome.
Watch
ICYMI: Top Content From DDW 2022
December 16th 2022Several therapeutic innovations in the management of Clostridioides difficile infection recurrence, current evidence on the efficacy of weight loss procedures in reversing nonalcoholic fatty liver disease, and an interview the use of artificial intelligence were spotlighted at Digestive Disease Week (DDW) 2022.
Read More